MyAverix Finance
SA · Healthcare
Vertex Pharmaceuticals Incorporated (VRTX34)
Biotechnology
Vertex Pharmaceuticals Incorporated (VRTX34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $590.04B, P/E ratio is 28.44, net margin is 32.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VRTX34
Vertex Pharmaceuticals Incorporated (VRTX34) — FAQ
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated (VRTX34) has a reported market cap of $590.04B (data as of 2026-03-29).
What is VRTX34's P/E ratio?
The price-to-earnings (P/E) ratio for Vertex Pharmaceuticals Incorporated (VRTX34) is 28.44 (data as of 2026-03-29).
Does Vertex Pharmaceuticals Incorporated pay a dividend?
Dividend yield is not available in the current snapshot for Vertex Pharmaceuticals Incorporated (VRTX34). Check the MyAverix Finance app for the latest dividend data.
What sector is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated (VRTX34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VRTX34 listed on?
VRTX34 is listed on SA.
What is Vertex Pharmaceuticals Incorporated's net margin?
Vertex Pharmaceuticals Incorporated (VRTX34) reports a net margin of 32.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.